Condition: Liver Fibrosis · Sponsor: Beijing Continent Pharmaceutical Co, Ltd.
This study is a Phase IIIb extension trial following the "A Randomized, Double-blind, Placebo-controlled, Multicenter, Entecavir-based, Phase III Clinical Trial of Hydronidone Capsule in the Treatment of Liver Fibrosis Associated with Chronic Hepatitis B". The main objective of this study is to evaluate the effectiveness and the safety of hydronidone capsules for long-term treatment of patients with chronic viral hepatitis B liver fibrosis.
This description comes directly from the study's public registry record.
Ling Zhang, Dr · +86-13501209210 · zhangling@bjcontinent.com
Always discuss trial participation with your own doctor first.
| Beijing Ditan Hospital Capital Medical University | Beijing, Beijing Municipality, China | Recruiting |
| Shanghai General Hospital,Shanghai Jiao Tong University | Shanghai, Shanghai Municipality, China | Recruiting |
| Beijing youan hospital, the capital of the capital | Beijing, China | Recruiting |
| Tsinghua Changgeng Hospital, Beijing | Beijing, China | Recruiting |
| The First Affiliated Hospital of Bengbu Medical University | Bengbu, China | Recruiting |
| The Second Xiangya Hospital, Central South University | Changsha, China | Recruiting |
| Xiangya Hospital, Central South University | Changsha, China | Recruiting |
| The First Affiliated Hospital of Chongqing Medical University | Chongqing, China | Recruiting |
| Three Gorges Hospital affiliated to Chongqing University | Chongqing, China | Recruiting |
| Guizhou Provincial People's Hospital | Guizhou, China | Recruiting |
| Hangzhou Xixi Hospital (Hangzhou Sixth People's Hospital) | Hangzhou, China | Recruiting |
| Henan Provincial People's Hospital | Henan, China | Recruiting |
+ 11 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05905172